B. Braun CeGaT LLC

As a service provider in the field of medicine and biotechnology, CeGaT offers decryption of genetic information and the medical interpretation of its data. CeGaT is the first company in the world to combine human genetic diagnostics with next generation sequencing, a new method for decrypting genetic information. In 2010 CeGaT developed so-called diagnostic panels which, for the first time could be used to decode all genes related to a certain disease simultaneously. CeGaT and B. Braun have been cooperative partners for many years. B. Braun is a 30 percent shareholder of CeGaT. In June of 2014, both companies founded a subsidiary in the USA together with B. Braun Medical US, called B. Braun CeGaT, LLC, headquartered in Pennsylvania. *

	Start	2014-06-01 established jv
	Group	B. Braun (Group)
	Industry	DNA/RNA sequencing
	Industry 2	personalised medicine / precision medicine

	City	n. a. Pennsylvania
		Address record changed: 2018-07-18

Basic data	Employees	n. a.

		* Document for »About Section«: CeGaT GmbH. (7/17/18). "Press Release: Precision Medicine – B. Braun China Enters a New Business Segment".

		Record changed: 2023-07-10